Wockhardt’s experimental drug, Zaynich, has shown impressive results, achieving a 100% cure rate in clinical trials for ...

In the midst of a worsening global health crisis, researchers are turning to an unlikely hero: Neem (Azadirachta indica), a plant that has been used for centuries to treat various ailments, including ...

Pune: Doctors have reported a steady increase in infections resistant to antibiotics among children in the city, indicating that humans without the usual risk factors are developing symptoms which ...

Although the use of colistin is considered to be effective, other antibiotics are often used in combination with colistin. Many studies have shown good outcomes for patients treated with colistin ...

Drugmaker Wockhardt has got off to an optimistic start this year with its novel antibiotic nafithromycin (Miqnaf) getting regulatory approval from the Central Drugs Standard Control Organization.

Shares of Wockhardt are higher by 5% on January 3 after Indian drug regulator approved oral antibiotic for the treatment of Pneumonia, the company informed in an exchange filing. Central Drugs ...

Miqnaf is an ultra-short course, once-a-day, three-day treatment for CABP, including infections caused by multi-drug resistant (MDR) pathogens. The approval follows a positive recommendation from the ...

Azithromycin may cause mild side effects other than those listed here. See the drug’s prescribing information for details. Azithromycin may cause serious side effects. The following list may not ...

Substance abuse in the United States is one of the leading health conditions impacting millions of lives and due to many types of drug addictions. Since 2000, there have been 700,000 overdose deaths ...

Azithromycin is a versatile antibiotic used to treat a wide variety of bacterial infections, including those affecting the ...